Ironwood Pharmaceuticals has appointed Thomas Graney as chief financial officer and senior vice president of finance and corporate strategy and Lisa Adler as senior vice president of corporate communications.
Before he joined the company, Graney was global vice president of finance and CFO at Ethicon, a world leader in surgical medical devices and a Johnson & Johnson (J&J) company.
Ms. Adler earlier served as vice president of corporate communications for Millennium: The Takeda Oncology Company.
Michael Higgins, who was CFO and chief operating officer (COO) of Ironwood, has said he will leave the company.
However, he intends to remain as COO through December 2014 to ensure a smooth transition.
CEO Peter Hecht said : "As Ironwood executes on our strategy of building a leading GI company, we are judiciously adding new capabilities to enable continued growth while improving the effectiveness and productivity of the organization. We're incredibly fortunate to have experienced industry leaders like Tom and Lisa join our executive team, and we look forward to their contributions as we seek to maximize the potential of our marketed and investigational medicines to create value for patients and for our fellow shareholders. Michael has been instrumental in building Ironwood: he has been a critical force in setting our strategy and establishing the solid financial base on which we brought our first medicine to patients. He has decided to look for a greater challenge outside of Ironwood and will be missed."